医学
螺内酯
盐皮质激素受体
肾脏疾病
内科学
心脏病学
安慰剂
内分泌学
醛固酮
泌尿科
病理
替代医学
作者
Sanjay Rajagopalan,Mirela Dobre,Jean‐Eudes Dazard,Armando Vergara-Martel,Kim A. Connelly,Michael E. Farkouh,Juan Gaztañaga,Heather Conger,Ann M. Dever,Laleh Razavi-Nematollahi,Anas Fares,Gabriel Tensol Rodrigues Pereira,Jonnelle M. Edwards,Mark J. Cameron,Cheryl Cameron,Sadeer Al‐Kindi,Robert D. Brook,Bertram Pitt,Matthew R. Weir
出处
期刊:Circulation
[Lippincott Williams & Wilkins]
日期:2024-08-12
卷期号:150 (9): 663-676
被引量:1
标识
DOI:10.1161/circulationaha.123.067620
摘要
Persistent mineralocorticoid receptor activation is a pathologic response in type 2 diabetes and chronic kidney disease. Whereas mineralocorticoid receptor antagonists are beneficial in reducing cardiovascular complications, direct mechanistic pathways for these effects in humans are lacking.
科研通智能强力驱动
Strongly Powered by AbleSci AI